Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women

other OA: green CC-BY-4.0
AI-generated summary by claude@2026-06, 2026-06-07

This study found no significant differences in peritoneal fluid corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) levels between healthy women and those with adhesions or endometriosis, except for slightly higher CRF-BP in stage 2/3 endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

This study measured immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in peritoneal fluid and compared levels to plasma in healthy women and women with pelvic adhesions or endometriosis, using immunoradiometric assay for CRF and radioimmunoassay for CRF-BP (peritoneal fluid n=35; groups included controls n=12, adhesions n=8, endometriosis n=15). Peritoneal fluid CRF and CRF-BP concentrations were lower than plasma values and did not vary with menstrual cycle phase, and there were no significant differences in peritoneal CRF or CRF-BP between healthy women and those with adhesions or endometriosis when analyzed against controls. In women with endometriosis, overall differences were not significant, but stage 2 and stage 3 disease showed higher peritoneal fluid CRF-BP than healthy women or those with lower-grade disease. The paper explicitly frames an interpretation as limited involvement of CRF in endometriosis-related immunological changes, but its small sample sizes and single-time peritoneal sampling are key limitations in assessing stage-specific effects. This paper is centrally about endometriosis — it quantifies peritoneal CRF and CRF-BP levels in women with endometriosis versus controls.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Corticotropin-releasing factor (CRF) is a 41-amino acid neurohormone involved in the neuroendocrine response to stress, also playing a role in cell-mediated immune functions and in inflammation. In the light of recent evidence showing an association between endometriosis and altered cellular immunity factors, the present study investigates immunoreactive (ir) CRF in the peritoneal fluid of healthy women, and in patients with pelvic adhesions and endometriosis. In addition, peritoneal fluid concentrations of CRF-binding protein (CRF-BP), a 37-kDA protein of 322 amino acids able to modulate central and peripheral CRF functions, were evaluated. Peritoneal fluid samples (n = 35) were collected from healthy women (n = 12), from patients with intrapelvic adhesions (n = 8), and from women with endometriosis (n = 15). In the control group a specimen of blood was collected. Peritoneal fluid and plasma CRF levels were measured by a two-site immunoradiometric assay (IRMA), and CRF-BP levels were measured by a specific radioimmunoassay (RIA). CRF and CRF-BP levels in peritoneal fluid were lower than plasma values, and independent of the phase of the menstrual cycle: in particular, in healthy women there was no significant difference between peritoneal fluid and plasma CRF-BP levels during two phases of the menstrual cycle. Peritoneal fluid levels of CRF and CRF-BP were similar in healthy patients and women with pelvic adhesions or with endometriosis, and when patients with adhesions or with endometriosis were considered as single group, no difference in CRF and CRF-BP levels was noted in comparison to the control group. In patients with endometriosis, no significant differences in peritoneal fluid CRF or CRF-BP levels were recorded, although in patients with stage 2 and stage 3 of the disease peritoneal fluid CRF-BP levels were higher than in healthy patients or in those with a lower grade of the disease. These results suggest that the peritoneal concentration of these hormones may reflect the circulating levels: the absence of any significative variations in peritoneal fluid CRF levels according to the degree of the endometriosis, suggests a limited role of CRF in the immunological changes related to the disease
Full text 8,988 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Corticotropin-releasing factor (CRF) is a 41-amino acid neurohormone involved in the neuroendocrine response to stress, also playing a role in cell-mediated immune functions and in inflammation. In the light of recent evidence showing an association between endometriosis and altered cellular immunity factors, the present study investigates immunoreactive (ir) CRF in the peritoneal fluid of healthy women, and in patients with pelvic adhesions and endometriosis. In addition, peritoneal fluid concentrations of CRF-binding protein (CRF-BP), a 37-kDA protein of 322 amino acids able to modulate central and peripheral CRF functions, were evaluated. Peritoneal fluid samples (n=35) were collected from healthy women (n=12), from patients with intrapelvic adhesions (n=8), and from women with endometriosis (n=15). In the control group a specimen of blood was collected. Peritoneal fluid and plasma CRF levels were measured by a two-site immunoradiometric assay (IRMA), and CRF-BP levels were measured by a specific radioimmunoassay (RIA). CRF and CRF-BP levels in peritoneal fluid were lower than plasma values, and independent of the phase of the menstrual cycle: in particular, in healthy women there was no significant difference between peritoneal fluid and plasma CRF-BP levels during two phases of the menstrual cycle. Peritoneal fluid levels of CRF and CRF-BP were similar in healthy patients and women with pelvic adhesions or with endometriosis, and when patients with adhesions or with endometriosis were considered as single group, no difference in CRF and CRF-BP levels was noted in comparison to the control group. In patients with endometriosis, no significant differences in peritoneal fluid CRF or CRF-BP levels were recorded, although in patients with stage 2 and stage 3 of the disease peritoneal fluid CRF-BP levels were higher than in healthy patients or in those with a lower grade of the disease. These results suggest that the peritoneal concentration of these hormones may reflect the circulating levels: the absence of any significative variations in peritoneal fluid CRF levels according to the degree of the endometriosis, suggests a limited role of CRF in the immunological changes related to the disease. Similar content being viewed by others

References

Smith E.M., Morrill A.C., Meyer III W.J., Blalock J.E. Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 321: 881, 1986. Kavelaars A., Berkenbosch F., Croiset G., Ballieux R.E., Heijnen C.J. Induction of β-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor. Endocrinology 126: 759, 1990. Angioni S., Petraglia F., Gallinelli A., et al. Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells. Life Sci. 33: 1733, 1993. Jain R., Zwickler D., Hollander C.S., Brand H., et al. Corticotropin-releasing factor modulates the immune response to stress in the rat. Endocrinology 128: 1329, 1991. Audhya T., Brand H., Hollander C.S. Suppression of natural killer cytotoxicity in human peripheral T lymphocytes by corticotropin-releasing factor: an in vitro model of in vivo effects. Clin. Res. 38: 595A, 1990. Webster E.L., Tracey D.E., Jutila M.A., Wolfe S.A., De Souza E.B. Corticotropin-releasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages. Endocrinology 127: 440, 1990. Audhya T., Jain R., Hollander C.S. Receptor-mediated immunomodulation by corticotropin-releasing factor. Cell. Immunol. 134: 77, 1991. Karalis K., Sano H., Redwine J., Listwak S., Wilder R.L., Chrousos G.P. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254: 421, 1991. Stephanou A., Jessop D.S., Knight R.A., Lightman S.L. Corticotropin-releasing factor-like immunoreactivity and mRNA in human leukocytes. Brain Behav. Immunol. 4: 67, 1990. Orth D.N. Corticotropin-releasing hormone in humans. Endocr. Rev. 13: 164, 1992. Potter E., Behan D.P., Fischer W.H., Linton E.A., Lowry P.J., Vale W. CDNA cloning and characterization of the human and rat corticotropin-releasing factor-binding protein. Nature 349: 423, 1991. Potter E.A., Behan D.P., Linton E.A., Lowry P.J., Sawchenko P.E., Vale W. The central distribution of a CRF-binding protein predicts multiple sites and mode of interactions with CRF. Proc. Natl. Acad. Sci. USA 89: 4192, 1992. Petraglia F., Potter V.A., Cameron A., Sutton S., Behan D.P., Woods R.J., Sawchenko P.E., Lowry P.J., Vale W. Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J. Clin. Endocrinol. Metab. 77: 919, 1993. Linton E.A., Perkins A., Woods R.J., Eben F., Wolfe C.D.A., Behan D.P., Potter E., Vale W.W., Lowry P.J. Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. J. Clin. Endocrinol. Metab. 76: 260, 1993. Perkins A.V., Eben F., Wolfe C.D.A., Schultze H.M., Linton E.A. Plasma measurements of corticotrophin-releasing hormone-binding protein in normal and abnormal-human pregnancy. J. Endocrinol. 138: 149, 1993. Suda T., Iwashita M., Tozawa F., Ushigawa T., Tomori N., Nakagami Y., Demura M., Shizume K. Characterization of corticotropin-releasing hormone binding protein in human plasma by chemical cross-linking and its binding during pregnancy. J. Clin. Endocrinol. Metab. 67: 1278, 1988. Suda T., Iwashita M., Sumitomo T., Nakano Y., Tozawa F., Demura H. Presence of CRH-binding protein in amniotic fluid and in umbilical cord plasma. Acta Endocrinol. (Copenh) 125: 165, 1991. Oosterlynck D., Meuleman C., Waer M., Vandeputte M., Koninckx P.R. The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil. Steril. 58: 290, 1992. Braun D.P., Muriana A., Gebel H., Rotman C., Rana N., Dmowski W.P. Monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis. Fertil. Steril. 61: 78, 1994. American Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil. Steril. 43: 351, 1985. Linton E.A., Wolfe C.D.A., Behan D.P., Lowry P.J. A specific carrier substance for human CRF in late gestational maternal plasma which could mask the ACTH-releasing activity. Clin. Endocrinol. (Oxf.) 28: 315, 1988. Woods R.J., Grossman P., Saphier P., Kennedy E., Ur E., Behan D., Potter E., Vale W., Lowry P.J. Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clearance of the complex. J. Clin. Endocrinol. Metab. 78: 73, 1994. Konickx P.R., Renaer M., Brosens I.A. Origin of peritoneal fluid women: an ovarian exudation product. Br. J. Obstet. Gynecol. 87: 177, 1980. Makrigiannakis A., Zoumakis E., Margioris A.N., Theodoropoulos P., Stournaras C., Gravanis A. The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium. J. Clin. Endocrinol. Metab. 79: 185, 1995. Dmowski W.P., Radwanska E. Current concepts on pathology, histogenesis and aetiology of endometriosis. Acta Obstet. Gynecol. Scand. 123 (Suppl.): 29, 1984. Mastorakos G., Scopa C.D., Vtyonidu A., Friedman T.C., Kattis D., Phenekos C., Merino M.J., Chronsos G.P. Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries. J. Clin. Endocrinol. Metab. 79: 1191, 1994. Merchentaler I., Hynes M.A., Vigh S., Schally A.V., Petrusz P. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat spinal cord. Brain Res. 275: 373, 1983. Petraglia F., Segre A., Facchinetti F., Campanini D., Ruspa M., Genazzani A.R. β-endorphin and met-enkephalin in peritoneal and ovarian follicular fluids of fertile and postmenopausal women. Fertil. Steril. 44: 615, 1985. Hemmings R., Falcone T., Billiar R., Tulandi T. Peritoneal fluid inhibin during the menstrual cycle. Obstet. Gynecol. 80: 27, 1992. Viganò P., Pardi R., Magri B., Busacca M., Di Blasio A.M., Vignali M. Expression of intercellular adhesion molecule-1 (ICAM-I) on cultured human endometrial stromal cells and its role in the interaction with natural killers. Am. J. Reprod. Immunol. 32: 139, 1994. Woods R.J., David J., Baigent S., Gibbins J., Lowry P.J. Elevated levels of corticotropin-releasing factor-binding protein in the blood of patients suffering from arthritis and septicaemia and the presence of novel ligands in synovial fluids. Br. J. Rheumatol. 35: 120, 1996. Author information Authors and Affiliations Rights and permissions About this article Cite this article Florio, P., Busacca, M., Vignali, M. et al. Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women. J Endocrinol Invest 21, 37–42 (1998). https://doi.org/10.1007/BF03347284 Accepted: Published: Issue date: DOI: https://doi.org/10.1007/BF03347284

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Ascitic Fluid Carrier Proteins Corticotropin-Releasing Hormone Endometriosis Adult Ascitic Fluid Carrier Proteins Corticotropin-Releasing Hormone Corticotropin-Releasing Hormone Endometriosis Female Follicular Phase Humans Immunoradiometric Assay Luteal Phase Pelvis Reference Values Tissue Adhesions

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
pubmed
last seen: 2026-05-13T22:10:40.754221+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine